4000-520-616
欢迎来到免疫在线!(蚂蚁淘生物旗下平台)  请登录 |  免费注册 |  询价篮
主营:主营:分子类,蛋白类,抗体类,生化类试剂
咨询热线电话
4000-520-616
当前位置: 首页 > 产品中心 > peptide > bioporto/Anti-Fibronectin (bovine, human)/1kit/CSI 005-32
商品详细bioporto/Anti-Fibronectin (bovine, human)/1kit/CSI 005-32
bioporto/Anti-Fibronectin (bovine, human)/1kit/CSI 005-32
bioporto/Anti-Fibronectin (bovine, human)/1kit/CSI 005-32
商品编号: CSI005-32
市场价: ¥0.00
美元价: 0.00
产地: 美国(厂家直采)
公司:
产品分类: 多肽合成
公司分类: peptide
联系Q Q: 3392242852
电话号码: 4000-520-616
电子邮箱: info@ebiomall.com
商品介绍
Cat. No.
CSI 005-32
Specificity
CSI 005-32 is highly specific for fibronectin. There is no evidence for cross-reactivity with otherconnective tissue proteins (vitronectin, elastin, collagen, laminin). The antibody inhibits cell adhesion tofibronectin mediated by the heparin-binding domain.
Immunogen
Bovine corneal endothelial cells
Host
Mouse
Positive Species Reactivity
Bovine, Human
Negative Species Reactivity
Not determined
Isotype
IgG1/k
Gene ID
280794 (2335)
Clone Number
A32
Epitope Specificity
Epitope is located in the 40kD Hep II heparin-binding domain, but differs from that of CSI 005-35
Unit Size
200 µL: Cat. No. CSI 005-32-021 mL: Cat. No. CSI 005-32-11 mg/mL +/- 15%. See Certificate of Analysis for details.
Purification
Protein A/G purified (from culture supernatant)
Form
Liquid
Solvent
0.01 M phosphate buffer, pH 7.4, containing 0.5 M NaCl and 15 mM sodium azide
Conjugation
Unconjugated BSA free
Storage
4-8ºC without exposure to light. No precautions necessary during handling.
Target
Fibronectin is an adhesive glycoprotein with a molecular mass of 440 kDa. It is believed to be important for the formation of a provisional matrix that promotes cell adhesion and migration during wound healing. Its age-dependent increase in plasma and tissues may be accompanied in pathological states, especially in tumor growth, by its proteolytic breakdown by a number of neutral proteases. It has also shown that several of its proteolytic breakdown products exhibit unexpected and mostly harmful biological activities. (1)
品牌介绍
  丹麦Bioporto公司成立于2000年,致力于开发抗体产品及诊断试剂盒。2005年首次开发出NGAL ELISA 试剂盒,该产品于2006年获得欧盟CE认证,可用于急性肾功能损伤的临床诊断和监测。其目标是开发出更多的临床诊断专利产品。